Editorial companion

What stands out

Novartis fell after pelacarsen failed a final-stage study and the company paused an experimental cell therapy, while Nordex jumped on a BofA upgrade and Soitec surged after lifting Photonics-SOI guidance and forecasting 2.5x, 3x growth in that segment. Bloomberg’s Stock Movers packages those three headlines into a single-day study of market mechanics: binary biotech outcomes, cyclical re-ratings, and a structural semiconductor-materials story all move prices fast. For investors, it is a clear snapshot of why single headlines can create outsized, short-lived market distortions.